Recombinant Human KCC1 Protein (HEK293)，His & Flag

KCC1, or the potassium chloride co-transporter 1, is a vital member of the solute carrier (SLC) superfamily, playing a crucial role in maintaining cell volume, pH balance, and ion homeostasis. It is predominantly expressed in various tissues, including the brain, kidney, and epithelial cells. Dysregulation of KCC1 function has been implicated in several pathological conditions, such as hypertension, cerebral edema, and neurological disorders. Consequently, the study of recombinant KCC1 protein has gained significant attention, focusing on its functional characterization, structural biology, and potential therapeutic implications. Researchers employ various molecular biology techniques to express and purify KCC1 in heterologous systems, allowing for in-depth studies on its transport mechanisms and regulatory pathways. Understanding the structure-function relationship of KCC1 is critical to deciphering its role in physiological processes and its involvement in disease states, which may pave the way for the development of novel pharmacological interventions targeting this transporter. As the demand for effective treatments for related disorders increases, the study of KCC1 and its recombinant protein forms stands to contribute valuable insights into both basic science and clinical applications.